Last reviewed · How we verify
Blood coagulation Factor VIII and vWF, human — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Blood coagulation Factor VIII and vWF, human (Blood coagulation Factor VIII and vWF, human) — CSL Behring.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Blood coagulation Factor VIII and vWF, human TARGET | Blood coagulation Factor VIII and vWF, human | CSL Behring | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Blood coagulation Factor VIII and vWF, human CI watch — RSS
- Blood coagulation Factor VIII and vWF, human CI watch — Atom
- Blood coagulation Factor VIII and vWF, human CI watch — JSON
- Blood coagulation Factor VIII and vWF, human alone — RSS
Cite this brief
Drug Landscape (2026). Blood coagulation Factor VIII and vWF, human — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-coagulation-factor-viii-and-vwf-human. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab